All Applications Open!
Apply Now
University of Michigan School of Public Health hosted national public health leaders Arnold Monto, Georges Benjamin and Boris Lushniak and historian Marian Moser Jones for a Democracy Week panel exploring public health’s 250-year impact on American life, the erosion of public trust, and what the next generation must do to rebuild it.
Today’s influenza vaccines primarily prevent infection in individuals, but new research led by the University of Michigan and the Institut Pasteur suggests that incorporating antibodies generated after infection could lead to more powerful vaccines by also reducing person-to-person transmission.
In the early 1940s, researchers at the University of Michigan School of Public Health played a critical role in developing and testing the first flu vaccine.
One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about 30%, according to new research in the New England Journal of Medicine from University of Michigan researchers.
Aubree Gordon, professor of Epidemiology and Global Public Health, has been awarded a $6.7 million five-year grant to advance her innovative research into influenza immunity development among children.
US flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says University of Michigan School of Public Health researcher Arnold Monto.